An online platform that offers public and private companies, across multiple industries the ability to stay active and engaged with the investment community.
#WhatThisMeans
: A Major Inflection Point - The Moleculin Opportunity in 2024 and Beyond Series (Part 2 of 3). CEO, Wally Klemp, summarizes recent progress and emphasizes the potential value of Annamycin.
$MBRX
@moleculinbio
#Oncology
#VirtualInvestor
#WhatThisMeans
! John Climaco, CEO of
@CNS_pharma
, highlights the recent clinical trial update on Berubicin and what it means for $CNSP. Watch the video here:
#GBM
#WhatThisMeans
! CEO of
@GRI_BIO
, Dr. Hertz, highlights how the recent sale of legacy ADAIR asset provides development milestones and allows company to focus on the advancement of innovative NKT pipeline for
#inflammatorydiseases
. Watch here: $GRI
#WhatThisMeans
: A Major Inflection Point - The Moleculin Opportunity in 2024 and Beyond Series (Part 1 of 3). CEO, Wally Klemp, summarizes recent progress and emphasizes the potential value of Annamycin.
$MBRX
@moleculinbio
#Oncology
#VirtualInvestor
We are pleased to welcome Dr. Bianco, CEO of
@tuhurabio
to our
#CEOCorner
& discuss the Company’s innovative platform technologies that are designed to overcome two major obstacles that limit the effectiveness of cancer
#immunotherapies
.
#CancerVaccines
#SaveTheDate
: We will be hosting the Virtual Investor Event: “A Breakthrough Medical Device for the Diagnosis and Treatment of Diseases of the Nervous System” on 12/11 at 2 PM ET. Register here:
@AutonomixMed
#Electrophysiology
#MedTech
CEO of $AREC, Mark Jensen and Marion Mayor, Ronald Morrell, Jr. discuss their recent milestone of bringing
#RareEarthElement
and
#LithiumProduction
Back to the United States with Receipt of Certificate of Occupancy for Marion, Indiana Supersite.
#WhatThisMeans
: Wally Klemp, CEO of $MBRX, highlights recent positive clinical and encouraging safety data for
#Annamycin
, a next generation chemotherapy that has the potential to make a significant impact on treatment for patients.
#Oncology
Check out our recent
#KOLConnect
with
@GRI_Bio
and prominent key opinion leader in
#IdiopathicPulmonaryFibrosis
discussing
#IPF
, the patient journey, and how they are working to advance their lead program as a potential therapeutic solution for IPF.
$GRI
Check out our latest
#KOLConnect
with members of
@SonnetBio
and world-renowned leaders in
#pancreaticcancer
, Sant Chawla, MD and Andrew Hendifar, MD, discussing $SONN recent clinical collaboration to advance SON-1210.
Access the video here:
#WhatThisMeans
-
#PositiveToplineResults
: Dr. Chris McAleer, Scientific Officer of $AIM Immunotech, discusses the Company’s Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions.
#LongCovid
Mark Jensen, CEO of
@Amerresources
joins us for a
#CEOConnect
to discuss actions the Company is taking to unlock value, the teams responsible for driving the businesses forward, and the focus of each business line.
$AREC
#RareEarths
#BatteryRecycling
We are hosting the
#AskTheCEO
Conference! An event intended to provide the investment community with access to ask questions directly to management. Turn on notifications for updates about the event and the final line up of presenting companies!
#WhatThisMeans
:
#TuneIn
to the CEOs of $CYTH and $AMTI highlighting the recently announced definitive merger agreement and their planned path forward primarily focused on advancing Trappsol® Cyclo™ for the treatment of
#NPC1
.
#BioDeal
#Merger
We are hosting the 2022 Top Picks Conference January 25-27, 2022. Access the event, its schedule and pre-submit questions at:
$AEZS $AREC $AIM $CZO $CRBP $CNSP $CYTH $NVNO
@iTolerance_inc
@Melzi_Surgical
$MBRX $OTLK $SING $VLON
@Viewpoint_MT
$XBIO
Join us for our first Virtual Investor Fireside Chat Series featuring in-depth conversations with CEOs of companies in a variety of industries, June 15-17th. Visit the event site for info:
$AREC $ARTH $VCNX $XBIO $NAVB $CZO $SLBG $OTLK $MOTS
.
@Novan_Biotech
leverages its proprietary nitric oxide-based science and technology platform to develop innovative, first-in-class therapies for unmet medical needs. Join their
#roundtable
discussion on Tues, Oct. 27th at 12PM ET. $NOVN
#BiotechInvesting
We've announced the lineup and schedule for our KOL Roundtable event! Join us October 27-29, 2020. Visit our website for more information:
$VCNX $NOVN $PLX $ARTH $OTLK $EVFM
#investorswelcomed
#roundtable
#paneldiscussion
#MarkYourCalendars
: We are pleased to feature Melzi Surgical for the Virtual Investor Innovations in MedTech Event on Wednesday, June 8 at 11:00 AM ET. Access the event here:
#VirtualInvestor
#MedTech
Save the date! We're thrilled to announce an upcoming event that you won't want to miss featuring
@GRI_BIO
Make sure to mark your calendars for July 27th at 1 PM ET.
$GRI
#VirtualInvestor
#SaveTheDate
JTC Team to Host Virtual Investor Innovations in Intestinal Health - Launching a Pivotal Phase 3 Study for Return of Postoperative Bowel Function Featuring Palisade Bio. The event will take place on Friday, September 16th at 11:00 am ET.
$PALI
#SaveTheDate
: We are hosting the Innovations in Intestinal Health - Launching a Pivotal Phase 3 Study for Return of Postoperative Bowel Function Event on Friday, September 16th at 11 AM ET. Access the event here:
$PALI
#VirtualInvestor
#RetailInvestor
Join us for our first Virtual Investor Fireside Chat Series featuring in-depth conversations with CEOs of companies in a variety of industries, June 15-17th. Visit the event site for info:
$AREC $ARTH $VCNX $XBIO $NAVB $CZO $SLBG $OTLK
Join us at 12PM ET to watch
@SlingerBag
CEO
@MikeBallardie
speak about how the company is innovating game improvement equipment for all ball sports, with an initial focus on the global tennis market with the Slinger Bag: $SLBG
#VirtualInvestor
Be sure to tune in to our next participating company! Outlook Therapeutics is presenting at 3:00 PM ET! Access the webcast here:
$OTLK
#VirtualInvestor
#RetailInvestor